Plain-English translation of NCT06995664 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether giving radiation therapy in fewer, higher doses over 2 weeks works as well as spreading the same total dose over more sessions. Researchers are comparing a 5-session schedule to a 10-session schedule, both delivering the same total amount of radiation to kidney cancer tumors. The goal is to see if the shorter schedule is just as safe and effective while being more convenient for patients.
Current standard radiation for kidney cancer requires 10 visits over 2 weeks. If a shorter 5-visit schedule works just as well, it could save patients time and make treatment more practical, especially for those who have difficulty traveling to appointments.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to receive either 5 radiation sessions or 10 radiation sessions over 2 weeks—both groups get the same total radiation dose, just on different schedules. You'll have an initial planning appointment, a CT scan for treatment planning, clinic visits during treatment weeks 1 and 2, a safety check 4 weeks after radiation ends, and follow-up visits at 3, 6, and 12 months. During your time in the study, you'll also complete quality-of-life questionnaires and have blood tests to monitor your health.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United Kingdom